Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Argatroban, Rt-PA”

4 trials

Showing 4 of 4 results

Post-approval studies (Phase 4)Study completedNCT03740958
What this trial is testing

Argatroban Plus R-tPA for Acute Ischemic Stroke

Who this might be right for
Stroke
General Hospital of Shenyang Military Region 808
Post-approval studies (Phase 4)Ended earlyNCT03506009
What this trial is testing

Argatroban Plus r-tPA for Posterior Circulation Infarction（AR-PCI）

Who this might be right for
Argatroban, Rt-PA
Hui-Sheng Chen 3
Testing effectiveness (Phase 2)Ended earlyNCT01464788
What this trial is testing

Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke

Who this might be right for
Ischemic Stroke
Andrew D. Barreto, MD 90
Testing effectiveness (Phase 2)Study completedNCT02448069
What this trial is testing

Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke

Who this might be right for
StrokeCerebral Ischemia
The University of Texas Health Science Center, Houston 10

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation